Drug-Induced Liver Injury (DILI): A Major Challenge

Drug-induced liver injury (DILI) is the most common cause for acute liver failure in the USA and Europe. DILI is also a leading cause of attrition of compounds in drug development and one of the two most

BoostDILI: Extreme Gradient Boost-Powered Drug-Induced Liver

Early prediction of DILI is crucial for developing safer pharmaceuticals, yet current in vitro and in vivo testing methods are complex and cumbersome. In this study, we developed an extreme

Mastering DILI: Strategies for Safer Drugs

Drug-induced liver injury (DILI) is a major concern in the pharmaceutical industry, as it is a leading cause of drug failure and withdrawal from the market. Understanding the complexities of

Drug-induced liver injury: Diagnosis, management and

In this paper, we summarize the pathophysiology, diagnosis, medical management, and LT for DILI. Keywords: Liver failure, liver injury, toxic hepatitis.

Load Shifting: What Is It and How Does It Work?

Load shifting is an electricity management technique that shifts load demand from peak hours to off-peak hours of the day. In this article, we explore what is load shifting, its purpose, load shifting vs peak

Drug-induced liver injury

Drug-induced liver injury (DILI) and herbal-induced liver injury (HILI) are well-recognized and symptomatically can mimic both acute and chronic liver diseases.

Drug-induced liver injury: Diagnosis, management and the role of liver

Drug-induced liver injury (DILI) is caused by various medications or herbals/nutritional supplements resulting in liver test abnormalities or hepatic dysfunction.

Exploring Individual Variability in Drug-Induced Liver Injury (DILI

With this aim, we explored the utility of assessing changes in the plasma metabolomic profiles of 79 DILI patients assessed by the RUCAM (Roussel Uclaf Causality Assessment Method) score to better

Drug-Induced Liver Injury (DILI): A Practical Review

DILI can be caused by a wide variety of compounds, including antibiotics, anticonvulsants, antidepressants, and herbal supplements. The risk of DILI is increased in patients

Drug Induced Liver Injury Rank (DILIrank) Dataset | FDA

The DILIrank dataset consists of 1,036 FDA-approved drugs that are divided into four classes according to their potential for causing drug-induced liver injury (DILI).

Download Complete Article (PDF)

Includes full article with technical specifications and reference links

Recent Articles

Technical Documentation & Specifications

Get technical specifications, product datasheets, and installation guides for our energy storage solutions, including commercial batteries, demand management systems, DC-coupled storage, portable units, and 100kWh ESS.

Contact ELALMACÉN SOLAR

Headquarters

Calle de la Energía, 25
28001 Madrid, Spain

Phone

+34 91 234 5678 (Sales)

+34 91 876 5432 (Technical)

Monday - Friday: 9:00 AM - 6:00 PM CET